Table 1 Main demographic and clinical characteristics of the study sample. p values were calculated with Mann–Whitney U test.

From: Clinical outcomes of combined Preserflo Microshunt implantation and cataract surgery in open-angle glaucoma patients

Variable

Overall

PMS

PMS + Phaco

p

Age, years

Mean ± SD

70.8 ± 6.6

70.4 ± 6.8

71.5 ± 6.1

0.529

Sex, n (%)

Women

30 (51.7%)

19 (54.3%)

11 (47.8%)

0.789a

Men

28 (48.3%)

16 (45.7%)

12 (52.2%)

IOP, mmHg

Mean ± SD

21.5 ± 3.3

21.3 ± 3.2

21.7 ± 3.5

0.761

NOHM

Mean ± SD

2.3 ± 0.5

2.3 ± 0.5

2.4 ± 0.5

0.581

BCVA

Mean ± SD

0.5 ± 0.2

0.6 ± 0.1

0.4 ± 0.1

< 0.001

MD, dB

Mean ± SD

6.2 ± 3.9

− 6.0 ± 3.7

− 6.5 ± 4.2

0.690

Glaucoma type, n (%)

OAG

45 (77.6%)

27 (77.1%)

18 (78.3%)

0.973b

PEX

10 (17.2%)

6 (17.1%)

4 (17.4%)

PIG

3 (5.2%)

2 (5.7%)

1 (4.3%)

  1. aFisher exact test.
  2. bChi-squared test.
  3. N number of eyes, SD standard deviation, IOP intraocular pressure, NOHM number of ocular hypotensive medications, PMS Preserflo Microshunt, BCVA best corrected visual acuity, MD mean defect, OAG open-angle glaucoma, PEX pseudoexfoliative glaucoma, PIG pigmentary glaucoma.